Loretta Nastoupil
Medical oncologist with experience in both large academic and community settings, offering expertise on real-world application, logistics, and patient selection for CAR T-cell therapy.
Best podcasts with Loretta Nastoupil
Ranked by the Snipd community
Dec 11, 2025 • 59min
CAR T-Cell Therapy for Non-Hodgkin Lymphoma | Cancer Q&A — Discussing Common Questions Posed by Patients
In this insightful discussion, Dr. Jeremy S Abramson, a lymphoma specialist at Massachusetts General Hospital, and Dr. Loretta J Nastoupil from CommonSpirit Mercy Hospital explore the landscape of CAR T-cell therapy for non-Hodgkin lymphoma. They delve into patient access challenges, revealing under 20% of eligible patients reach treatment centers. The pair compare CAR T products and emphasize the importance of logistical support for patients. They also address the significance of wellness strategies and community collaboration in enhancing patient care.
Sep 14, 2023 • 1h 1min
Inside the Issue: The Current and Future Role of CD20 x CD3 Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma
Experts Dr Martin Hutchings and Dr Loretta Nastoupil discuss the current and future role of CD20 x CD3 bispecific antibodies in the management of non-Hodgkin lymphoma. Topics include different agents, efficacy, tolerability, dose step up, treatment duration, challenges in generating order sets, patient experience, comparing immunotherapies, and side effect profiles.
